Načítá se...
Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review
BACKGROUND: Since the implementation of the Regulation on Patient Integration (2003), the Act on the Reorganization of the Pharmaceutical Market (2011), and the Patient Rights Law (2013), the inclusion of patient perspectives has been further anchored in the German early benefit assessment process....
Uloženo v:
| Vydáno v: | Health Econ Rev |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6909645/ https://ncbi.nlm.nih.gov/pubmed/31832812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13561-019-0251-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|